Nuwacell

Biotech · Hefei, Anhui · Founded 2016 · Privately Held (backing)

Developer of cell therapy products designed for Induced Pluripotent Stem Cells (iPSC). Nuwacell is based in Hefei, Anhui and was founded in 2016. Its last reported valuation was $203 million in Jun 2022. It has raised $63.7 million across 2 recorded rounds; the latest was an $11.6 million Series B (final close) in Apr 2025.

Last reported valuation
$202.5M
Oct 2026
Priced at
—
Total raised
$63.7M
Last round
Series B (final close)
Apr 2025
How much has Nuwacell raised?
$63.7Macross 2 recorded rounds · Nov 2024 – Apr 2025

Most recently, Nuwacell raised $11.6M in its Series B (final close) (Apr 2025).

Free account
More of Nuwacell with a free account
  • ·The complete investor list: 11 names
  • ·Everyone on the team, board and advisors included
  • ·Watch Nuwacell: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nuwacell round by round

2 rounds
Apr 2025Series B (final close)$11.6M▮
Nov 2024Series B (first close)$21.0M▮

How much has Nuwacell raised?

Nuwacell has raised $63.7 million in total; 2 of its rounds are on record. The largest on record was a $21 million Series B (first close) in Nov 2024; the most recent was an $11.6 million Series B (final close) in Apr 2025.

Nuwacell investors

11 investors are on record for Nuwacell, including Hefei Industry Investment Group, Legend Capital, Hefei Hi-Tech VC and GF Xinde Investment Management. By type, the record holds 4 venture capital firms and 1 private equity firm.

For fundraisers
Raising for a company like Nuwacell?

11 investors have backed Nuwacell — start your target list with the firms already writing checks in biotech.

See all 11 investors →

Frequently asked about Nuwacell

How much has Nuwacell raised?
Nuwacell has raised $63.7M in total across 2 recorded funding rounds.
When was Nuwacell's last funding round?
Nuwacell's most recent recorded round was Series B (final close) in Apr 2025, raising $11.6M.